##### 



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 Washington, DC 20549
 FORM 10-Q
 þ
    
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
 For the quarterly period ended March 31, 2007
 o
    
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
 Commission file number 001-33269
 CHINA HEALTHCARE ACQUISITION CORP.
  Delaware
    
    20-5013347(State or other jurisdiction of Incorporation or organization)
    
    (I.R.S. Employer Identification No.)1233 Encino DrivePasadena, CA
    
    91108(Address of principal executive offices)
    
    (Zip Code)
 (626) 568-9924
 o þ
  o o þ




---



##### 



CHINA HEALTHCARE ACQUISITION CORPORATION
 Table of Contents
 PagePART I  FINANCIAL INFORMATIONItem 1. Condensed Financial Statements (unaudited)Condensed Balance Sheets
    
    3Condensed Statements of Operations
    
    4Condensed Statements of Stockholders Equity
    
    5Condensed Statements of Cash Flows
    
    6Notes to Condensed Financial Statements
    
    7Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
    
    11Item 3. Quantitative and Qualitative Disclosures about Market Risk
    
    13Item 4T. Controls and Procedures
    
    13PART II  OTHER INFORMATIONItem 1. Legal Proceedings
    
    13Item 1A. Risk Factors
    
    13Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
    
    14Item 3. Defaults upon Senior Securities
    
    14Item 4. Submission of Matters to a Vote of the Security Holders
    
    14Item 5. Other Information
    
    14Item 6. Exhibits
    
    15SIGNATURES
    
    16INDEX TO EXHIBITSCertification by Principal Executive Officer Pursuant to Section 302Certification by Principal Financial Officer Pursuant to Section 302Certification by Principal Executive Officer and Principal Financial Officer Pursuant to Section 906
 2




---



##### 



Item 1. Financial Statements
 CHINA HEALTHCARE ACQUISITION CORP.
(a development stage company)
 CONDENSED BALANCE SHEET
 UnauditedMarch 31,
    
    
    December 31,2007
    
    
    2006ASSETSCurrent AssetsCash
    
    $
    46,123
    
    
    $
    49,349Cash in trust
    
    
    1,503,617
    
    
    
    Total Current Assets
    
    
    1,549,740
    
    
    
    49,349Deferred offering costs
    
    
    436,697
    
    
    
    331,479TOTAL ASSETS
    
    $
    1,986,437
    
    
    $
    380,828LIABILITIES AND STOCKHOLDERS EQUITYCurrent LiabilitiesAccounts payable and accrued expenses
    
    
    310,700
    
    
    
    208,828Due to stockholder
    
    
    1,503,744
    
    
    
    Notes payable to stockholders
    
    
    150,000
    
    
    
    150,000TOTAL LIABILITIES
    
    
    1,964,444
    
    
    
    358,828COMMITMENTSSTOCKHOLDERS EQUITYPreferred stock  $.0001 par value; 1,000,000
shares authorized; 0 issued and outstanding
    
    
    
    
    
    
    Common stock  $.0001 par value; 50,000,000 shares
authorized; 2,125,000 and 2,500,000 issued and
outstanding, respectively
    
    
    213
    
    
    
    250Additional paid-in capital
    
    
    24,787
    
    
    
    24,750Deficit accumulated during the development stage
    
    
    (3,007
    )
    
    
    (3,000
    )Total stockholders equity
    
    
    21,993
    
    
    
    22,000TOTAL LIABILITIES & STOCKHOLDERS EQUITY
    
    $
    1,986,437
    
    
    $
    380,828
  3




---



##### 



CHINA HEALTHCARE ACQUISITION CORP.
(a development stage company)
 CONDENSED STATEMENT OF OPERATIONS
 Unaudited
    
    
    UnauditedPeriod from January 1,
    
    
    Period from June 7,2007
    
    
    2006 (inception)to March 31, 2007
    
    
    to March 31, 2007Interest income
    
    $
    13
    
    
    $
    13Formation and operating costs
    
    
    20
    
    
    
    3,020Net income (loss)
    
    $
    (7
    )
    
    $
    (3,007
    )Net income (loss) per share
    
    $
    (0.00
    )
    
    $
    (0.00
    )Weighted average number of
shares outstanding
    
    
    2,225,000
    
    
    
    2,416,667
  4




---



##### 



CHINA HEALTHCARE ACQUISITION CORP.
(a development stage company)
 STATEMENT OF STOCKHOLDERS EQUITY
 For the period from June 7, 2006 (inception) to March 31, 2007
 Income (deficit)accumulatedAdditional
    
    
    during the
    
    
    TotalCommon Stock
    
    
    paid-in
    
    
    development
    
    
    StockholdersShares
    
    
    Amount
    
    
    capital
    
    
    stage
    
    
    EquityIssuance of common stock to founders and
insiders on June 7, 2006 at $.01 per share
    
    
    2,500,000
    
    
    $
    250
    
    
    $
    24,750
    
    
    
    
    
    
    $
    25,000Net Loss
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (3,000
    )
    
    
    (3,000
    )Balance at December 31, 2006
    
    
    2,500,000
    
    
    
    250
    
    
    
    24,750
    
    
    
    (3,000
    )
    
    
    22,000Unaudited:Surrender and cancellation of 375,000
shares of common stock by initial
stockholders on January 24, 2007
    
    
    (375,000
    )
    
    
    (37
    )
    
    
    37
    
    
    
    
    
    
    
    Net Income (loss)
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (7
    )
    
    
    (7
    )Balance  March 31, 2007
    
    
    2,125,000
    
    
    $
    213
    
    
    $
    24,787
    
    
    
    ($3007
    )
    
    $
    21,993
  
 5




---



##### 



CHINA HEALTHCARE ACQUISITION CORP.
(a development stage company)
 CONDENSED STATEMENTS OF CASH FLOWS
 Period from
    
    
    Period fromJanuary 1, 2007
    
    
    June 7, 2006to March 31,
    
    
    (inception) to2007
    
    
    March 31, 2007Cash Flows from Operating ActivitiesNet loss
    
    ($
    7
    )
    
    ($
    3,007
    )Net cash used in operating activities
    
    
    (7
    )
    
    
    (3,007
    )Cash Flows from Financing ActivitiesProceeds from issuance of common stock
    
    
    
    
    
    
    25,000Proceeds from the Chairman of the Board of
Director for the future purchase of warrants
    
    
    (1,503,617
    )
    
    
    (1,503,617
    )Increase in due to stockholder
    
    
    1,503,744
    
    
    
    1,503,744Proceeds from stockholders note payable
    
    
    
    
    
    
    150,000Payment of proposed offering costs
    
    
    (3,346
    )
    
    
    (125,997
    )Net cash
provided by (used) in financing activities
    
    
    (3,219
    )
    
    
    49,130Net increase
(decrease) in cash
    
    
    (3,226
    )
    
    
    46,123Cash  beginning of period
    
    
    49,349
    
    
    
    Cash  end of period
    
    $
    46,123
    
    
    $
    46,123Supplemental schedule of non-cash financing activity:Accrual of costs of proposed offering
    
    
    101,872
    
    
    
    310,700
  
 6




---



##### 



CHINA HEALTHCARE ACQUISITION CORP.
(A Development Stage Company)
 NOTES TO FINANCIAL STATEMENTS
March 31, 2007
 Note 1  Interim Financial Information
   Note 2  Summary of Significant Accounting Policies
 Nature of Business
  Development Stage Company
   7




---



##### 



Use of estimates
  Recent Accounting Standards
   Net loss per share
  Income Taxes
  8




---



##### 



Note 3  Deferred Offering Costs
  Note 4  Note Payable to Stockholder
    Note 5  Stockholders Equity
  Note 6  Commitments
    Note 7 Subsequent Event
  9




---



##### 



Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Companys
Own Stock.
    10




---



##### 



Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
    RESULTS OF OPERATIONS
 Net Loss
  CHANGES IN FINANCIAL CONDITION
 Liquidity and Capital Resources
     
    
    Payment of the purchase price for the business combination;
    
    Payment of the non-accountable expense allowance and the deferred portion of the underwriting discount due to the underwriters;
    
    Payment of any finders fees or professional fees and costs; and
    
    Payment of any fees and costs the Company may incur in connection with any equity or
debt financing relating to the business combination.
 11




---



##### 




    
    approximately $200,000 for legal, accounting and other expenses attendant to the
structuring and negotiating of a business combination;
    
    approximately $300,000 for the due diligence and investigation of a target business;
    
    approximately $115,000 in legal and accounting fees relating to our SEC reporting obligations;
    
    approximately $120,000 in fees relating to our office space and certain general and administrative services;
    
    approximately $240,000 for travel, general working capital that will be used for
miscellaneous expenses and reserves, including for director and officer liability insurance
premiums, deposits, down payments and/or funding of a no shop provision in connection
with a prospective business transaction and for international travel with respect to
negotiating and finalizing a business combination;
    
    approximately $150,000 for repayment of the loan from our Chairman; and
    
    approximately $75,000 for a reserve for liquidation expenses.
     Off-Balance Sheet Arrangements
  Contractual Obligations
  12




---



##### 



Forward Looking Statements
  Item 3. Quantitative and Qualitative Disclosures About Market Risk.
  Item 4T. Controls and Procedures.
    PART II  OTHER INFORMATION
 Item 1  Legal Proceedings
  Item 1A  Risk Factors
  13




---



##### 



Item 2  Unregistered Sales of Equity Securities and Use of Proceeds.
   Item 3  Defaults upon Senior Securities
  Item 4  Submission of Matters to a Vote of the Security Holders
  Item 5  Other Information
  14




---



##### 



Item 6  Exhibits
 Number
    
    Description31.1
    
    Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 200231.2
    
    Certification by Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 200232.1
    
    Certification by Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 Sarbanes-Oxley Act of 200232.2
    
    Certification by Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 Sarbanes-Oxley Act of 2002
 15




---



##### 



SIGNATURES
  CHINA HEALTHCARE ACQUISITION CORP.Date: June 4, 2007
    By:
    /s/ Alwin TanAlwin TanChief Executive Officer and Treasurer(Principal Executive Officer)By:
    /s/ Steven WangSteven WangVice President
(Principal Financial and Accounting Officer) 16




---



##### 



INDEX TO EXHIBITS
 Number
    
    Description31.1
    
    Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 200231.2
    
    Certification by Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 200232.1
    
    Certification by Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 Sarbanes-Oxley Act of 200232.2
    
    Certification by Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 Sarbanes-Oxley Act of 2002
 17